Abstract:AIM:To construct the subunit vaccine and DNA vaccine based on heat shock protein 65 (HSP65) of M.tuberculosis H37Rv (MTB) and to evaluate the immunological properties. METHODS:The gene of hsp 65 was amplified from DNA genome of MTB H37Rv strain by polymerase chain reaction (PCR). The PCR product was inserted into pMD18-T vector and sequenced. The HSP65 gene segment was subcloned into prokaryotic expression vector pProEX HTb and eukaryotic expression vector pcDNA3.1 (-) respectively. The former was expressed in E.coli DH5α.The target protein was identified by SDS-PAGE analysis and by Western Blot with monoclonal antibody against MTB HSP 65 and sera from clinical TB patients. Recombinant 6×His fused protein was purified by Ni-NTA purification system; the eukaryotic recombinant plasmid was transfected into P815 cells by Suohua-sofast transfection reagent, and the expression was identified by indirect immunofluorescent technology. RESULTS: The sequence of PCR product was identical with that of HSP65 gene in GenBank. Relative molecular mass identified by SDS-PAGE analysis was consistent with what had been reported, which was also confirmed by Western Blot analysis that there was a specific band at 65000 with the specific monoclonal antibody against MTB HSP65 and TB patients' sera, and there was a specific band between proteins expressed by transfected P815 and two antibodies above. CONCLUSION: The two vaccines of HSP65 are successfully constructed and possess the immunological properties. It will be helpful in further studies on diagnosis and therapy of tuberculosis.

Purification and Stability Research of Mycobacterial Heat Shock Protein 65 and Its Fusion Protein Hsp65-6 P277

Expression and Purification of Heat Shock Protein 65(HSP65) of Mycobacterium Leprae and Preparation of Anti-HSP65 Polyclonal Antiserum

Expression and Purification of the Fusion Protein Comprising Mycobacterium Tuberculosis Heat Shock Protein 65 and Human Interleukin 2

Construction of subunit and DNA vaccine of heat shock protein 65 of Mycobacterium tuberculosis and their immunological properties

The Preparation of Mycobacterium Tuberculosis HSP65 DNA Vaccine and the Prokaryotic Expression of the Recombinant HSP65 Protein

The Expression and Purification of HSP65 Antigen from Mycobacterium Tuberculosis in E.Coli

Expression,purification and identification of Hsp-65 protein from Mycobacterium tuberculosis

Purification of a Non-Tagged Recombinant BCG Heat Shock Protein 65-Her2 Peptide Fusion Protein from Escherichia Coli.

Heterologous Expression of FMDV Immunodominant Epitopes and HSP70 in P. Pastoris and the Subsequent Immune Response in Mice

Effct of Heat Shock Protein 65 of Mycobacterium Tuberculosis on Prevention of Diabetes in Nonobese Diabetic Mice

Purification of clinical-grade recombinant HSP65-MUCI fusion protein.

Long-lasting specific antibodies against P277 induced by mucosal administration of P277 repeat sequences carried by Hsp65 in the absence of adjuvants.

Expression,purification and Identification of the Fusion Protein Ag85B-Hsp16.3 of Mycobacterium Tuberculosis

Enhanced Immunogenicity of Peptide P277 by Heat Shock Protein Hsp65 Vector Carrying Tandem Repeats of P277 to Prevent Type 1 Diabetes in Nod Mice

Expression and Purification of Secreted Recombinant Hsp60 from Eukaryotic Cells

Construction of a Eukaryotic Expression System of HSP65 Gene from Mycobacterium Tuberculosis, and Anti-Hsp65 IgG Produced in Mice.

The Basic Study and Purification Strategy of MAGE-1/MAGE-3/Heat Shock Protein 70 Fusion Protein Tumor Vaccine

Expression,purification and identification of Hsp16.3 protein from Mycobacterium tuberculosis

Expression And Purification Of Mycobacterium Tuberculosis Esat-6 And Mpt64 Fusion Protein And Its Immunoprophylactic Potential In Mouse Model

[Improved Efficacy of P277 Fused to Heat Shock Protein 65 of Mycobacterium Tuberculosis Against Diabetes in Nonobese Diabetic Mice].

Long-Lasting Specific Antibodies Against Cetp Induced by Subcutaneous and Mucosal Administration of A 26-Amino Acid Cetp Epitope Carried by Heat Shock Protein 65 Kda in the Absence of Adjuvants